MGP and neoplasm: RUNX2 has been shown to promote bone metastasis in breast cancer57 whilst MGP appears to act as a tumour suppressor in ER + breast cancer58, suggesting that the altered expression observed in these genes may help explain the unusually aggressive nature of calcification-associated tumours observed in some studies10,59.